Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of EXICURE INC
Analyst Grade Summary
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
5
1
0
0
No Price
01.05.2026 21:49
Current Prices from EXICURE INC
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
NASDAQ
XCUR
USD
01.05.2026 21:49
3,20 USD
-0,16 USD
-4,76 %
IEX
XCUR
USD
29.04.2026 14:10
3,33 USD
-
Share Float & Liquidity
Free Float28,11 %
Shares Float1,79 M
Shares Outstanding6,37 M
Company Profile for EXICURE INC Share
Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie Inc. to develop SNA-based treatments for hair loss disorders; and collaboration agreement with Ipsen S.A. to research, develop, and commercialize novel spherical nucleic acids for Huntington's disease and Angelman syndrome. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.
